IQVIA Laboratories at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

IQVIA Laboratories takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 410. Its sessions cover the lab work behind vaccine studies, from preclinical evaluation to outbreak response. The most concrete describes rapidly developing assays for Bundibugyo virus (BDBV) so that Ebola BDBV vaccine studies can go ahead.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
labs.iqvia.com
CRO, CDMO & labsDiamond sponsor
Laboratory services for drug discovery and development, including central laboratory and specialty biomarker services.
Booth
Exhibiting at Booth 410
Talk
Tue Oct 20
14:00
Talk
Wed Oct 21
11:00
Driving Vaccines into the Clinic – Implementing a Proven Preclinical Evaluation Platform Approach
Clinical Trials

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from IQVIA Laboratories

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction